D
Daniel J. Lenihan
Researcher at Vanderbilt University Medical Center
Publications - 166
Citations - 9052
Daniel J. Lenihan is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Heart failure & Cancer. The author has an hindex of 32, co-authored 140 publications receiving 6193 citations. Previous affiliations of Daniel J. Lenihan include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Alexander R. Lyon,Teresa López-Fernández,Liam Couch,Riccardo Asteggiano,Marianne C Aznar,Jutta Bergler-Klein,Giuseppe Boriani,Daniela Cardinale,Raul Cordoba,Bernard Cosyns,D Cutter,Evandro de Azambuja,W. De Boer,Susan Dent,Dimitrios Farmakis,Sofie Gevaert,D. Gorog,A. Herrmann,Daniel J. Lenihan,Javid Moslehi,Brenda Moura,Sonja S Salinger,R. Stephens,Thomas M. Suter,Sebastian Szmit,Juan Tamargo,Paaladinesh Thavendiranathan,Carlo G. Tocchetti,P. Van Der Meer,Helena J H van der Pal +29 more
Journal ArticleDOI
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
Mathew S. Maurer,Mazen Hanna,Martha Grogan,Angela Dispenzieri,Ronald M. Witteles,Brian M. Drachman,Daniel P. Judge,Daniel J. Lenihan,Stephen S. Gottlieb,Sanjiv J. Shah,D. Eric Steidley,Hector O. Ventura,Srinivas Murali,Marc A. Silver,Daniel Jacoby,Savitri Fedson,Scott L. Hummel,Arnt V. Kristen,Thibaud Damy,Violaine Planté-Bordeneuve,Teresa Coelho,Rajiv Mundayat,Ole B. Suhr,Márcia Waddington Cruz,Claudio Rapezzi +24 more
TL;DR: In the THAOS registry, ATTR in the United States is overwhelmingly a disorder of older adult male subjects with a cardiac-predominant phenotype, and neurologic phenotypic expression differs between wild-type disease and Val122Ile, but survival from enrollment in ThAOS does not.
Journal ArticleDOI
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Alexander R. Lyon,Teresa López-Fernández,Liam Couch,Riccardo Asteggiano,Marianne C. Aznar,Jutta Bergler-Klein,Giuseppe Boriani,Daniela Cardinale,Raul Cordoba,Bernard Cosyns,D Cutter,Evandro de Azambuja,W. De Boer,Susan Dent,Dimitrios Farmakis,Sofie Gevaert,Diana A. Gorog,A. Herrmann,Daniel J. Lenihan,Javid Moslehi,Brenda Moura,Sonja S Salinger,R. Stephens,Thomas M. Suter,Sebastian Szmit,Juan Tamargo,Paaladinesh Thavendiranathan,Carlo G. Tocchetti,P. Van Der Meer,Helena J H van der Pal +29 more
Journal ArticleDOI
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
TL;DR: The patient is a 63-year-old man with a history of well-controlled hypertension who is diagnosed with diffuse large B-cell lymphoma and treated with a doxorubicin-containing chemotherapy regimen, and is continued on hydrochlorothiazide for his hypertension.
Journal ArticleDOI
Cancer Therapy–Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging
Michelle W. Bloom,Carine E. Hamo,Daniela Cardinale,Bonnie Ky,Anju Nohria,Lea Baer,Hal Skopicki,Daniel J. Lenihan,Mihai Gheorghiade,Alexander R. Lyon,Javed Butler +10 more
TL;DR: This review focuses on adult patients in all stages of cancer therapy from pretreatment surveillance, to ongoing therapy, and long-term follow-up, and concludes with a section on evidence gap and future directions.